Dual contraceptive use among women living with HIV on anti-retroviral therapy in Boset district, Ethiopia.

IF 2.3 Q2 OBSTETRICS & GYNECOLOGY
Frontiers in global women's health Pub Date : 2025-04-01 eCollection Date: 2025-01-01 DOI:10.3389/fgwh.2025.1510299
Yohanes Abera Belachwe, Midekso Sento, Melese Negash Gobena, Mihiret Shawel Getahun, Yohannes Mekuria Negussie
{"title":"Dual contraceptive use among women living with HIV on anti-retroviral therapy in Boset district, Ethiopia.","authors":"Yohanes Abera Belachwe, Midekso Sento, Melese Negash Gobena, Mihiret Shawel Getahun, Yohannes Mekuria Negussie","doi":"10.3389/fgwh.2025.1510299","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The World Health Organization advocates dual contraceptive methods for women with Human Immunodeficiency Virus (HIV) to prevent unintended pregnancies and sexually transmitted infections (STIs), enhancing education, economic opportunities, and maternal-child health outcomes. However, persistent global challenges stem from inadequate use of dual contraceptives and unsafe sexual practices, resulting in high rates of unintended pregnancies and significant health risks. Hence, this study aimed to assess dual contraceptive use among women living with HIV on anti-retroviral therapy (ART) in Boset District, Ethiopia.</p><p><strong>Method: </strong>A facility-based cross-sectional study was conducted among 342 women living with HIV from September 12 to October 18, 2023. Participants were selected by systematic random sampling, and data were collected using an interviewer-administered structured questionnaire. The collected data were entered using Epi Info version 7.2.6 and analyzed using SPSS version 26.0. Bivariable and multivariable binary logistic regression analyses were performed to assess the association between the outcome and explanatory variables. In the multivariable analysis, an adjusted odds ratio (AOR) with a 95% confidence interval (CI) was used to show the strength of the association, and the level of significance was set at a <i>p</i>-value of <0.05.</p><p><strong>Results: </strong>The magnitude of dual contraceptive use was 33.7% (95% CI: 28-40). Urban residence (AOR = 2.5; 95% CI: 1.97-8.08), good knowledge about dual contraceptives (AOR = 3.8; 95% CI: 2.36-8.67), STIs history in the past 12 months (AOR = 2.6, 95% CI: 1.25-4.72) and having two or more number of sexual partners, (AOR = 1.9; 95% CI: 1.18-6.68), were factors significantly associated with dual contraceptive use.</p><p><strong>Conclusion: </strong>One-third of women living with HIV on ART utilized dual contraceptives. Place of residence, knowledge about dual contraceptives, history of STIs in the past 12 months, and number of sexual partners were factors associated with dual contraceptive use. It is essential to implement focused educational programs to increase knowledge about dual contraceptives, alongside expanding access to contraceptive services in rural and underserved areas.</p>","PeriodicalId":73087,"journal":{"name":"Frontiers in global women's health","volume":"6 ","pages":"1510299"},"PeriodicalIF":2.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11996836/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in global women's health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fgwh.2025.1510299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The World Health Organization advocates dual contraceptive methods for women with Human Immunodeficiency Virus (HIV) to prevent unintended pregnancies and sexually transmitted infections (STIs), enhancing education, economic opportunities, and maternal-child health outcomes. However, persistent global challenges stem from inadequate use of dual contraceptives and unsafe sexual practices, resulting in high rates of unintended pregnancies and significant health risks. Hence, this study aimed to assess dual contraceptive use among women living with HIV on anti-retroviral therapy (ART) in Boset District, Ethiopia.

Method: A facility-based cross-sectional study was conducted among 342 women living with HIV from September 12 to October 18, 2023. Participants were selected by systematic random sampling, and data were collected using an interviewer-administered structured questionnaire. The collected data were entered using Epi Info version 7.2.6 and analyzed using SPSS version 26.0. Bivariable and multivariable binary logistic regression analyses were performed to assess the association between the outcome and explanatory variables. In the multivariable analysis, an adjusted odds ratio (AOR) with a 95% confidence interval (CI) was used to show the strength of the association, and the level of significance was set at a p-value of <0.05.

Results: The magnitude of dual contraceptive use was 33.7% (95% CI: 28-40). Urban residence (AOR = 2.5; 95% CI: 1.97-8.08), good knowledge about dual contraceptives (AOR = 3.8; 95% CI: 2.36-8.67), STIs history in the past 12 months (AOR = 2.6, 95% CI: 1.25-4.72) and having two or more number of sexual partners, (AOR = 1.9; 95% CI: 1.18-6.68), were factors significantly associated with dual contraceptive use.

Conclusion: One-third of women living with HIV on ART utilized dual contraceptives. Place of residence, knowledge about dual contraceptives, history of STIs in the past 12 months, and number of sexual partners were factors associated with dual contraceptive use. It is essential to implement focused educational programs to increase knowledge about dual contraceptives, alongside expanding access to contraceptive services in rural and underserved areas.

埃塞俄比亚博塞特地区接受抗逆转录病毒治疗的感染艾滋病毒的妇女使用双重避孕药具。
背景:世界卫生组织提倡对感染人类免疫缺陷病毒(HIV)的妇女采用双重避孕方法,以防止意外怀孕和性传播感染(STIs),提高教育、经济机会和母婴健康结果。然而,持续存在的全球挑战源于双重避孕药具的不充分使用和不安全的性行为,导致意外怀孕率高和重大健康风险。因此,本研究旨在评估埃塞俄比亚Boset地区接受抗逆转录病毒治疗(ART)的艾滋病毒感染妇女使用双重避孕措施的情况。方法:于2023年9月12日至10月18日对342名感染HIV的妇女进行了基于设施的横断面研究。研究对象采用系统随机抽样的方式进行,数据收集采用访谈者管理的结构化问卷。收集的数据使用Epi Info 7.2.6版本录入,使用SPSS 26.0版本进行分析。采用双变量和多变量二元逻辑回归分析来评估结果与解释变量之间的关联。在多变量分析中,采用校正优势比(AOR)和95%置信区间(CI)来显示关联强度,显著性水平设置为结果的p值:双重避孕药使用的幅度为33.7% (95% CI: 28-40)。城市居民(AOR = 2.5;95% CI: 1.97-8.08),对双重避孕药具有良好的了解(AOR = 3.8;95% CI: 2.36-8.67),过去12个月的性传播感染史(AOR = 2.6, 95% CI: 1.25-4.72),有两个或两个以上的性伴侣(AOR = 1.9;95% CI: 1.18-6.68),是与双重避孕药使用显著相关的因素。结论:接受抗逆转录病毒治疗的艾滋病毒感染妇女中有三分之一使用双重避孕药。居住地、双重避孕药具知识、过去12个月性传播感染史和性伴侣数量是使用双重避孕药具的相关因素。必须实施重点突出的教育方案,提高人们对双重避孕药具的认识,同时扩大农村和服务欠缺地区获得避孕服务的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信